TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $97,000 | +18.3% | 72,696 | -0.4% | 0.00% | – |
Q4 2018 | $82,000 | -42.7% | 72,976 | +40.6% | 0.00% | – |
Q3 2018 | $143,000 | -22.3% | 51,887 | +0.6% | 0.00% | – |
Q2 2018 | $184,000 | +25.2% | 51,587 | +7.6% | 0.00% | – |
Q1 2018 | $147,000 | -56.9% | 47,962 | -11.5% | 0.00% | -100.0% |
Q4 2017 | $341,000 | -13.5% | 54,187 | -5.9% | 0.00% | 0.0% |
Q3 2017 | $394,000 | +7.1% | 57,593 | +11.5% | 0.00% | 0.0% |
Q2 2017 | $368,000 | -18.0% | 51,633 | +5.7% | 0.00% | 0.0% |
Q1 2017 | $449,000 | +162.6% | 48,853 | +14.9% | 0.00% | – |
Q4 2016 | $171,000 | -21.6% | 42,512 | -25.3% | 0.00% | -100.0% |
Q3 2016 | $218,000 | -11.7% | 56,945 | -0.9% | 0.00% | 0.0% |
Q2 2016 | $247,000 | +39.5% | 57,435 | +50.1% | 0.00% | 0.0% |
Q1 2016 | $177,000 | -53.1% | 38,255 | +1.8% | 0.00% | 0.0% |
Q4 2015 | $377,000 | +49.0% | 37,575 | +10.8% | 0.00% | 0.0% |
Q3 2015 | $253,000 | -83.8% | 33,915 | +3.1% | 0.00% | -80.0% |
Q2 2015 | $1,561,000 | +71.4% | 32,906 | +32.4% | 0.01% | +66.7% |
Q1 2015 | $911,000 | +14.3% | 24,856 | +23.8% | 0.00% | +50.0% |
Q4 2014 | $797,000 | +133.0% | 20,081 | +17.2% | 0.00% | +100.0% |
Q3 2014 | $342,000 | +48.1% | 17,131 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $231,000 | +102.6% | 17,131 | +63.9% | 0.00% | – |
Q1 2014 | $114,000 | +62.9% | 10,453 | +4.3% | 0.00% | – |
Q2 2013 | $70,000 | – | 10,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 664,000 | $2,543,000 | 0.82% |
GREAT POINT PARTNERS LLC | 452,375 | $1,733,000 | 0.44% |
Clearline Capital LP | 267,915 | $1,026,000 | 0.32% |
Rhenman & Partners Asset Management AB | 300,000 | $1,149,000,000 | 0.18% |
Rock Springs Capital Management LP | 662,500 | $2,537,000 | 0.16% |
Eventide Asset Management | 600,000 | $2,298,000 | 0.14% |
Granahan Investment Management | 657,496 | $2,518,000 | 0.08% |
Candriam S.C.A. | 374,000 | $1,432,000 | 0.03% |
Tekla Capital Management LLC | 192,322 | $737,000 | 0.03% |
DOW CHEMICAL CO /DE/ | 65,000 | $249,000 | 0.02% |